PLN and pulmonary arterial hypertension: However, chronic activation of GPER with G1 (400 μg/kg/day) attenuates the adverse effects of monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) on SERCA2a and the ratio of phosphorylated PLB to total PLB in an OVX model (20).